Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
27
2020
EPA Announces Continued Efforts to Help Increase Availability of Disinfectant Products for Use Against COVID-19 Bergeson & Campbell, P.C.
Mar
27
2020
US EPA Issues Temporary Policy on COVID-19 Implications for the Agency’s Enforcement and Compliance Assurance Program Squire Patton Boggs (US) LLP
Mar
26
2020
Massachusetts Issues COVID-19 Orders and Related Guidance for Pharmacies and Pharmacy Professionals Robinson & Cole LLP
Mar
26
2020
Marijuana Regulatory Agency Expediting Licenses for Home Delivery During COVID-19 Crisis Varnum LLP
Mar
26
2020
Physicians Committee for Responsible Medicine Files Lawsuit Against the State of California Alleging OEHHA Failed to Include Processed Meat on Prop 65 List Keller and Heckman LLP
Mar
26
2020
COVID-19: FDA Issues Guidance for Ventilator and Respirator Manufacturers Foley & Lardner LLP
Mar
26
2020
Crisis & Compliance: EU Competition Law During COVID-19 McDermott Will & Emery
Mar
26
2020
Legal Implications Of COVID-19 For Pharmaceutical And Medical Device Companies In France McDermott Will & Emery
Mar
25
2020
Top 10 Questions Asked By Medical Group Clients In Response To COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Mar
25
2020
Legal Implications of COVID-19 for Pharmaceutical and Medical Device Companies in the United Kingdom McDermott Will & Emery
Mar
25
2020
Stated Purpose More Decisive than Definition in Construing Claims McDermott Will & Emery
Mar
25
2020
US EPA Revises TSCA Chemical Data Reporting Requirements and Extends Deadline for 2020 Reporting Period Squire Patton Boggs (US) LLP
Mar
25
2020
COVID-19 Vaccine Test Lab Hit by Maze Ransomware Robinson & Cole LLP
Mar
25
2020
DEA Releases Draft Rules Related to Cannabis Medical Research Dinsmore & Shohl LLP
Mar
25
2020
False Advertisement and Unjust Enrichment Claims Against Kombucha Brewer Dismissed for Lack of Notice and Lack of Conferred Benefit Keller and Heckman LLP
Mar
25
2020
USDA Extends Comment Period for Salmonella Citizen Petition Keller and Heckman LLP
Mar
25
2020
Five Things Brand Owners Should Do Now To Guard Against Increase in Scams and Counterfeit Goods During COVID-19 Pandemic Dinsmore & Shohl LLP
Mar
25
2020
Florida Issues New Emergency Order Further Relaxing Licensure, Telehealth, and Practice Standards to Combat COVID-19 Foley & Lardner LLP
Mar
25
2020
Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure Robinson & Cole LLP
Mar
25
2020
FDA Seeks to Improve Ventilator Access, Relaxes REMS Requirements During COVID-19 McDermott Will & Emery
Mar
25
2020
Cannabusinesses Should Take Advantage of Their Extra Time to File Tax Returns to Ensure Proper Reductions in Their Taxable Income for Cost of Goods Sold Norris McLaughlin P.A.
Mar
24
2020
New OIG and FBI Announcements Highlight Coronavirus Fraud Schemes Targeting Americans Jones Walker LLP
Mar
24
2020
COVID-19 and the New Jersey Alcoholic Beverage Industry Norris McLaughlin P.A.
Mar
24
2020
Medical Marijuana Deemed “Essential” During COVID-19 Pandemic Epstein Becker & Green, P.C.
Mar
24
2020
Enforcers, Experts Discuss Tamping Down Anticompetitive Behavior in Bio Market During FDA/FTC Workshop MoginRubin
Mar
24
2020
FDA Eases Device Modification Rules to Expand Availability of Ventilators During COVID-19 Pandemic Epstein Becker & Green, P.C.
Mar
24
2020
COVID-19 – Legal Implications for Pharmaceutical and Medical Device Companies in Germany McDermott Will & Emery
Mar
24
2020
FDA Offers Guidance on Clinical Trials During COVID-19 Pandemic McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins